These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31379746)

  • 1. Melatonin: Clinical Perspectives in Neurodegeneration.
    Cardinali DP
    Front Endocrinol (Lausanne); 2019; 10():480. PubMed ID: 31379746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and healthy aging.
    Cardinali DP
    Vitam Horm; 2021; 115():67-88. PubMed ID: 33706965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin Therapy in Patients with Alzheimer's Disease.
    Cardinali DP; Vigo DE; Olivar N; Vidal MF; Brusco LI
    Antioxidants (Basel); 2014 Apr; 3(2):245-77. PubMed ID: 26784870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.
    Pérez-Lloret S; Cardinali DP
    Front Pharmacol; 2021; 12():650597. PubMed ID: 33935759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and mitochondrial dysfunction in the central nervous system.
    Cardinali DP; Pagano ES; Scacchi Bernasconi PA; Reynoso R; Scacchi P
    Horm Behav; 2013 Feb; 63(2):322-30. PubMed ID: 22391273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus.
    Wajid F; Poolacherla R; Mim FK; Bangash A; Rutkofsky IH
    J Diabetes Metab Disord; 2020 Dec; 19(2):1797-1825. PubMed ID: 33520862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin: Nature's most versatile biological signal?
    Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
    FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.
    Cardinali DP; Furio AM; Reyes MP
    Ann N Y Acad Sci; 2005 Dec; 1057():327-36. PubMed ID: 16399904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of melatonin and its derivatives in aging and neurodegenerative diseases.
    Verma AK; Singh S; Rizvi SI
    Biogerontology; 2023 Apr; 24(2):183-206. PubMed ID: 36550377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin in relation to cellular antioxidative defense mechanisms.
    Reiter RJ; Carneiro RC; Oh CS
    Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.
    Lahiri DK; Chen DM; Lahiri P; Bondy S; Greig NH
    Ann N Y Acad Sci; 2005 Nov; 1056():430-49. PubMed ID: 16387707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.
    Sanchez-Barcelo EJ; Rueda N; Mediavilla MD; Martinez-Cue C; Reiter RJ
    Curr Med Chem; 2017 Nov; 24(35):3851-3878. PubMed ID: 28721826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.
    Trotti LM; Karroum EG
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):63. PubMed ID: 27180068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retardation of brain aging by chronic treatment with melatonin.
    Bondy SC; Lahiri DK; Perreau VM; Sharman KZ; Campbell A; Zhou J; Sharman EH
    Ann N Y Acad Sci; 2004 Dec; 1035():197-215. PubMed ID: 15681809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model.
    Ali T; Badshah H; Kim TH; Kim MO
    J Pineal Res; 2015 Jan; 58(1):71-85. PubMed ID: 25401971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin in Alzheimer's disease and other neurodegenerative disorders.
    Srinivasan V; Pandi-Perumal SR; Cardinali DP; Poeggeler B; Hardeland R
    Behav Brain Funct; 2006 May; 2():15. PubMed ID: 16674804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    Nunomura A; Zhu X; Perry G
    J Alzheimers Dis; 2017; 55(1):73-75. PubMed ID: 27802241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.